In summary, we characterized inhibitory stromal subpopulations and established that fibronectin acts on stromal cell receptors to increase the production of chemotactic cytokines and enhance recruitment of anti-tumorigenic neutrophils leading to tumor suppression. The gene discussed is FN1; the disease is neoplasm.